EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review

Kyrie Eleyson R Baden, Halley McClain, Eliya Craig, Nathan Gibson, Juanita A Draime iD, Aleda M H Chen iD

Nutrients · 28.10.2024 · 16 (21) · 3668

DOI: 10.3390/nu16213668 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Nutrients, online erschienen am 28.10.2024. Verfasst von Kyrie Eleyson R Baden und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Cedarville University, Cedarville, OH 45314, USA. Hauptthemen laut MEDLINE: Liver, Liver Diseases, S-Adenosylmethionine. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: S-adenosylmethionine (SAMe) is a natural compound implicated in the treatment of liver dysfunction. In this systematic review, our objective was to determine the efficacy, safety, and optimal dose of SAMe in liver diseases.

Methods

Using the PRISMA methodology, we searched PubMed, CINAHL, and Web of Science using key MeSH search terms. For title/abstract screening, full-text review, and data extraction, two independent researchers reviewed articles, and a third researcher resolved conflicts. Data extraction also included a quality assessment of included articles.

Results

Of the 1881 non-duplicated studies, 15 articles focusing on SAMe use in the liver were included. All included studies (n = 15) scored a 4 or 5 out of 5 points on the quality assessment, which indicated high study quality. Overall, SAMe was effective in improving liver-related parameters with few adverse events, which were primarily mild, transient gastrointestinal complaints.

Conclusions

The most common doses were SAMe 1000 mg or 1200 mg per day with or without another treatment or natural supplement. Future studies are needed to assess long-term efficacy and safety data of SAMe and the optimal route of administration in liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiverLiver DiseasesS-AdenosylmethionineHumansDietary Supplements

Stichwörter der Autor:innen

S-adenosylmethionineSAMelivernutraceutical

Substanzen

S-Adenosylmethionine

Autor:innen und Institutionen

  • School of Pharmacy, Cedarville University, Cedarville, OH 45314, USA.

ORCID-Profile: Juanita A Draime, Aleda M H Chen

Zitieren

APA

Baden, K. E. R., McClain, H., Craig, E., Gibson, N., Draime, J. A., & Chen, A. M. H. (2024). S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review. Nutrients, 16(21), 3668. https://doi.org/10.3390/nu16213668

Vancouver

Baden KER, McClain H, Craig E, Gibson N, Draime JA, Chen AMH. S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review. Nutrients. 2024;16(21):3668. doi:10.3390/nu16213668

BibTeX
@article{Baden2024,
  author = {Baden, Kyrie Eleyson R and McClain, Halley and Craig, Eliya and Gibson, Nathan and Draime, Juanita A and Chen, Aleda M H},
  title = {S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {21},
  pages = {3668},
  doi = {10.3390/nu16213668}
}
Kostenlos starten →